Works matching IS 2574173X AND DT 2022 AND VI 42 AND IP 4

Results: 19

Issue Information.

Published in:: Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 397, doi. 10.1002/npr2.12187
Publication type:: Article

Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 516, doi. 10.1002/npr2.12299

By:

Tsujii, Takashi;
Sakurai, Hitoshi;
Takeuchi, Hiroyoshi;
Suzuki, Takefumi;
Mimura, Masaru;
Uchida, Hiroyuki

Publication type:

Article

Risk assessment of accidental falls in patients taking trazodone, quetiapine, or risperidone for insomnia: A single‐center, case–control study.

Published in:

2022

By:

Shimizu, Yoshihito;
Taga, Masatoshi;
Takahashi, Yoshimitsu;
Yamamoto, Yasuhiko;
Masauji, Togen

Publication type:

Case Study

Adolescent cannabis use and the later onset of bipolar disorder: protocol for a systematic review and meta‐analysis of prospective cohort studies.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 538, doi. 10.1002/npr2.12296

By:

Yasuma, Naonori;
Imamura, Kotaro;
Watanabe, Kazuhiro;
Iida, Mako;
Takano, Ayumi

Publication type:

Article

What outcomes in community mental health research are important to caregivers of people with schizophrenia? An exploratory qualitative analysis of an online survey.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 526, doi. 10.1002/npr2.12295

By:

Yasuma, Naonori;
Shiozawa, Takuma;
Ogawa, Makoto;
Abe, Makiko;
Igarashi, Momoka;
Kawaguchi, Takayuki;
Sato, Sayaka;
Nishi, Daisuke;
Kawakami, Norito;
Yamaguchi, Sosei;
Fujii, Chiyo

Publication type:

Article

Association between functional recovery and medication adherence in schizophrenia.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 510, doi. 10.1002/npr2.12294

By:

Ishii, Junpei;
Kodaka, Fumitoshi;
Miyata, Hisatsugu;
Yamadera, Wataru;
Seto, Hikaru;
Higuchi, Hidejiro;
Tsuruoka, Yoshiaki;
Shigeta, Masahiro

Publication type:

Article

Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 502, doi. 10.1002/npr2.12293

By:

Inada, Ken;
Fukumoto, Kentaro;
Hasegawa, Naomi;
Yasuda, Yuka;
Yamada, Hisashi;
Hori, Hikaru;
Ichihashi, Kayo;
Iida, Hitoshi;
Ohi, Kazutaka;
Muraoka, Hiroyuki;
Kodaka, Fumitoshi;
Ide, Kenta;
Hashimoto, Naoki;
Iga, Jun‐ichi;
Ogasawara, Kazuyoshi;
Atake, Kiyokazu;
Takaesu, Yoshikazu;
Nagasawa, Tatsuya;
Komatsu, Hiroshi;
Okada, Tsuyoshi

Publication type:

Article

Intracerebroventricular administration of oxytocin and intranasal administration of the oxytocin derivative improve β‐amyloid peptide (25–35)‐induced memory impairment in mice.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 492, doi. 10.1002/npr2.12292

By:

Takahashi, Junpei;
Ueta, Yudai;
Yamada, Daisuke;
Sasaki‐Hamada, Sachie;
Iwai, Takashi;
Akita, Tomomi;
Yamashita, Chikamasa;
Saitoh, Akiyoshi;
Oka, Jun‐Ichiro

Publication type:

Article

The association between body image, emotional health, relationships, and unhealthy dietary behaviors among medical sciences students: A structural equation modeling analysis.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 485, doi. 10.1002/npr2.12291

By:

Arabi‐Mianrood, Hoda;
Shahhosseini, Zohreh;
Tabaghdehi, Monirolsadate Hosseini

Publication type:

Article

A preliminary study on predictors of treatment response to repetitive transcranial magnetic stimulation in patients with treatment‐resistant depression in Japan.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 478, doi. 10.1002/npr2.12290

By:

Ikawa, Haruki;
Tochigi, Mamoru;
Noda, Yoshihiro;
Oba, Hiroshi;
Kaminaga, Tatsuro;
Sakurai, Keita;
Ikebuchi, Emi;
Hayashi, Naoki;
Kunugi, Hiroshi

Publication type:

Article

Central monitoring of depression and anxiety symptoms reduces placebo responses in depression clinical trials: A post hoc exploratory analysis of data from the phase III CCT‐004 trial of vortioxetine.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 468, doi. 10.1002/npr2.12288

By:

Watanabe, Yoshinori;
Nishimura, Akira;
Kikuchi, Toshiaki;
Sawada, Norifusa;
Imazaki, Manami;
Inada, Isao;
Watanabe, Koichiro

Publication type:

Article

Caffeine facilitates extinction of auditory fear conditioning in rats.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 521, doi. 10.1002/npr2.12287

By:

Ozawa, Takaaki;
Kaseda, Kodai;
Ichitani, Yukio;
Yamada, Kazuo

Publication type:

Article

Recent findings on subjective well‐being and physical, psychiatric, and social comorbidities in individuals with schizophrenia: A literature review.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 430, doi. 10.1002/npr2.12286

By:

He, Yupeng;
Tanaka, Ayako;
Kishi, Taro;
Li, Yuanying;
Matsunaga, Masaaki;
Tanihara, Shinichi;
Iwata, Nakao;
Ota, Atsuhiko

Publication type:

Article

Simultaneous monitoring of activity and heart rate variability in depressed patients: A pilot study using a wearable monitor for 3 consecutive days.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 457, doi. 10.1002/npr2.12285

By:

Koga, Norie;
Komatsu, Yoko;
Shinozaki, Ryo;
Ishida, Ikki;
Shimizu, Yusuke;
Ishimaru, Sonoko;
Kunugi, Hiroshi

Publication type:

Article

Topiramate and other kainate receptor antagonists for depression: A systematic review of randomized controlled trials.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 421, doi. 10.1002/npr2.12284

By:

Shamabadi, Ahmad

Publication type:

Article

Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta‐analysis of randomized controlled trials.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 410, doi. 10.1002/npr2.12283

By:

Ogasawara, Masaya;
Takeshima, Masahiro;
Esaki, Yuichi;
Kaneko, Yoshiyuki;
Utsumi, Tomohiro;
Aoki, Yumi;
Watanabe, Norio;
Suzuki, Masahiro;
Takaesu, Yoshikazu

Publication type:

Article

Relationship among psychotic features, benzodiazepine receptor agonists, and rehospitalization in patients with electroconvulsive therapy‐responsive major depressive disorder: A retrospective 2‐year observational study.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 449, doi. 10.1002/npr2.12282

By:

Umakoshi, Akise;
Takeshima, Masahiro;
Itoh, Yu;
Yamamoto, Mari;
Shibata, Nana;
Ogasawara, Masaya;
Ayabe, Naoko;
Mishima, Kazuo

Publication type:

Article

Findings of <sup>18</sup>F‐PI‐2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 437, doi. 10.1002/npr2.12281

By:

Bun, Shogyoku;
Moriguchi, Sho;
Tezuka, Toshiki;
Sato, Yoshiaki;
Takahata, Keisuke;
Seki, Morinobu;
Nakajima, Shinichiro;
Yamamoto, Yasuharu;
Sano, Yasunori;
Suzuki, Natsumi;
Morimoto, Ayaka;
Ueda, Ryo;
Tabuchi, Hajime;
Ito, Daisuke;
Mimura, Masaru

Publication type:

Article

Antidepressants for social anxiety disorder: A systematic review and meta‐analysis.

Published in:

Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 398, doi. 10.1002/npr2.12275

By:

Mitsui, Nobuyuki;
Fujii, Yutaka;
Asakura, Satoshi;
Imai, Hissei;
Yamada, Hisashi;
Yoshinaga, Naoki;
Kanai, Yoshihiro;
Inoue, Takeshi;
Shimizu, Eiji

Publication type:

Article